scispace - formally typeset
Y

Yara Cury

Researcher at Instituto Butantan

Publications -  81
Citations -  3170

Yara Cury is an academic researcher from Instituto Butantan. The author has contributed to research in topics: Hyperalgesia & Venom. The author has an hindex of 32, co-authored 78 publications receiving 2842 citations. Previous affiliations of Yara Cury include University of São Paulo.

Papers
More filters
Journal ArticleDOI

Pain and analgesia: The dual effect of nitric oxide in the nociceptive system

TL;DR: The information included in the present review aims to present and analyze data about the dual effect of NO on pain transmission and control, the molecular mechanisms involved in these effects and also the potential use of nitric oxide in pain therapy.
Journal ArticleDOI

Inflammatory effects of snake venom myotoxic phospholipases A2.

TL;DR: This work reviews the proinflammatory and nociceptive effects evoked by myotoxic PLA2s and their mechanisms of action and concludes that these proteins promote inflammation and pain by mechanisms not related to phospholipid hydrolysis nor to mobilization of arachidonic acid.
Journal ArticleDOI

Inflammation induced by Bothrops asper venom

TL;DR: The current status of the understanding of the inflammatory reaction, including pain, triggered by Bothrops asper venom is described and studies dealing with the mechanisms of inflammatory and nociceptive properties of phospholipases A(2), a metalloproteinase and serine-proteases isolated from both humans and experimental animals are described.
Journal ArticleDOI

Analgesic effect of He-Ne (632.8 nm) low-level laser therapy on acute inflammatory pain.

TL;DR: He-Ne LLLT inhibits the sensitization increase of nociceptors on the inflammatory process, and the analgesic effect seems to involve hyperalgesic mediators instead of peripheral opioid receptors.
Journal ArticleDOI

Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA.

TL;DR: It is suggested that administration of peptidomimetic metalloproteinase inhibitors or CaNa2EDTA at the site of venom injection may represent a useful alternative to complement antivenoms in the neutralization of venom-induced local tissue damage.